InvestorsObserver
×
News Home

Will Supernus Pharmaceuticals Inc (SUPN) Stay at the Top of the Healthcare Sector?

Friday, September 23, 2022 03:38 PM | InvestorsObserver Analysts

Mentioned in this article

Will Supernus Pharmaceuticals Inc (SUPN) Stay at the Top of the Healthcare Sector?

Supernus Pharmaceuticals Inc (SUPN) is near the top in its sector according to InvestorsObserver. SUPN gets an overall rating of 99. That means it scores higher than 99% of stocks. Supernus Pharmaceuticals Inc gets a 83 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

Overall Score - 99
SUPN has an Overall Score of 99. Find out what this means to you and get the rest of the rankings on SUPN!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Supernus Pharmaceuticals Inc Stock Today?

Supernus Pharmaceuticals Inc (SUPN) stock is trading at $32.83 as of 3:37 PM on Friday, Sep 23, a decline of -$0.11, or -0.33% from the previous closing price of $32.94. Volume today is low. So far 246,772 shares have traded compared to average volume of 405,002 shares. The stock has traded between $32.15 and $33.05 so far today. Click Here to get the full Stock Report for Supernus Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App